Document is current
Any future updates will be listed below
-
Authors
Lebon, Chiara
Grossmann, Sebastian
Mann, Greg
Lindner, Florian
Koide, Akiko
Koide, Shohei
Diepold, Andreas
Hantschel, Oliver
-
Funding
Funding for this research was provided by:
Philipps-Universität Marburg
- License Information
-
More Information
Article History
Received: 8 July 2024
Accepted: 4 October 2024
First Online: 16 October 2024
Declarations
:
: AK and SK are listed as inventors on issued and pending patents on the monobody technology filed by The University of Chicago (US Patent 9512199 B2 and related pending applications). SK is a co-founder, receives consulting fees and hold equity in Aethon Therapeutics; is a co-founder and holds equity in Revalia Bio; has received research funding from Aethon Therapeutics, Argenx BVBA, Black Diamond Therapeutics, and Puretech Health, all outside of the current work. AD and FL are listed as inventors on an issued patent on the light-controlled T3SS filed by Max Planck Innovation (WO/2020/201115). The other authors declare no competing interests.
